Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 2/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.48 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.42 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 5/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4757741 | 1.00 | GRIA1 (0.48) | GRIA1GRIA4GRIK5GRIA3SLC7A5 | |
| SCHEMBL5298700 | 0.98 | GRIA1 (0.47) | GRIA1GRIA4GRIK5GRIA3SLC7A5 | |
| SCHEMBL615017 | 0.95 | GRIA1 (0.52) | GRIA1GRIA4GRIK5GRIA3SLC7A5 | |
| SCHEMBL939749 | 0.95 | GRIA1 (0.52) | GRIA1GRIA4GRIK5GRIA3SLC7A5 | |
| SCHEMBL14485771 | 0.95 | GRIA1 (0.52) | GRIA1GRIA4GRIK5GRIA3SLC7A5 | |
| Benzoquinone SCHEMBL23630290 | 0.92 | GRIA1 (0.46) | GRIA1GRIA4GRIK5GRIA3SLC7A5 | |
| SCHEMBL612974 | 0.81 | GRIA1 (0.43) | GRIA1GRIA4GRIK5GRIA3 | |
| SCHEMBL9512449 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTL3MBTL1NPSR1TAAR1 | |
| SCHEMBL9512439 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTL3MBTL1NPSR1TAAR1 | |
| Hydrochloric Acid SCHEMBL11881163 | 0.79 | KDM4E (0.46) | ALDH1A1MAPTKDM4EHSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| US-20230090247-A1 | MOLECULES TARGETING RAS PROTEIN | VIB VZW (BE) | 2023-03-23 | — | — | US | disclosed |
| EP-4106787-A1 | MOLECULES TARGETING RAS PROTEIN | Aelin Therapeutics (BE) | 2022-12-28 | — | — | EP | disclosed |
| US-10017773-B2 | HSF-like transcription factor, TBF1, is a major molecular switch for growth-to-defense transition in plants | DUKE UNIVERSITY (US) | 2018-07-10 | — | — | US | disclosed |
| EP-1134283-B1 | Method for producing L-Phenylalanine | AJINOMOTO KK (JP) | 2005-09-14 | — | — | EP | disclosed |
| US-6350596-B2 | Method for producing L-phenylalanine | AJINOMOTO CO., INC. (JP) | 2002-02-26 | — | — | US | disclosed |
| US-20010044139-A1 | Method for producing L-phenylalanine | AJINOMOTO CO., INC. (JP) | 2001-11-22 | — | — | US | disclosed |
| EP-1134283-A1 | Method for producing L-Phenylalanine | Ajinomoto Co., Inc. (JP) | 2001-09-19 | — | — | EP | disclosed |
| EP-0138526-B1 | METHOD OF PRODUCING L-PHENYLALANINE BY FERMENTATION, AND BACTERIA THEREFOR | AJINOMOTO CO., INC. (JP) | 1989-04-26 | — | — | EP | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
| US-4591562-A | GENETIC ENGINEERING, INCORPORATING RECOMBINANT PLASMID DNA DERIVEDFROM BACILLUS | AJINOMOTO COMPANY INCORPORATED (JP) | 1986-05-27 | — | — | US | disclosed |
| EP-0073143-B1 | NOVEL COMPLEX AMIDO AND IMIDO DERIVATIVES OF CARBOXYALKYL PEPTIDES AND THIOETHERS AND ETHERS OF PEPTIDES | Ryan, James Walter (US) | 1985-11-21 | — | — | EP | disclosed |
| US-4407952-A | OF GENETICALLY ENGINEERED ESCHERICHIA | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-10-04 | — | — | US | disclosed |
| US-4403033-A | Method for producing L-phenylalanine by fermentation | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-09-06 | — | — | US | disclosed |
| EP-0073143-A2 | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | Ryan, James Walter (US) | 1983-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | PAICS, LNPEP, DNPEP | GRIA1 2608/4885GRIA4 3341/4885GRIK5 2808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.